These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3545672)

  • 1. Biosynthesis and processing of class II histocompatibility antigens.
    Cresswell P; Blum JS; Kelner DN; Marks MS
    Crit Rev Immunol; 1987; 7(1):31-53. PubMed ID: 3545672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early events in the assembly of major histocompatibility complex class II heterotrimers from their free subunits.
    Nijenhuis M; Neefjes J
    Eur J Immunol; 1994 Jan; 24(1):247-56. PubMed ID: 8020564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologically discrete conformation isomers of I-A locus-equivalent class II molecules detected in Lewis rats.
    Reske K; Weitzel R
    Eur J Immunol; 1985 Dec; 15(12):1229-39. PubMed ID: 3878790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the Ia-invariant chain complex in the posttranslational processing and transport of Ia and invariant chain glycoproteins.
    Simonis S; Miller J; Cullen SE
    J Immunol; 1989 Dec; 143(11):3619-25. PubMed ID: 2584710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the biosynthesis of cartilage proteoglycan in a model system of cultured chondrocytes from the Swarm rat chondrosarcoma.
    Kimura JH; Lohmander LS; Hascall VC
    J Cell Biochem; 1984; 26(4):261-78. PubMed ID: 6530407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine Ia-associated invariant chain's processing to complex oligosaccharide forms and its dissociation from the I-Ak complex.
    Holt GD; Swiedler SJ; Freed JH; Hart GW
    J Immunol; 1985 Jul; 135(1):399-407. PubMed ID: 3873494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens.
    Henne C; Schwenk F; Koch N; Möller P
    Immunology; 1995 Feb; 84(2):177-82. PubMed ID: 7750992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
    Spiro RC; Sairenji T; Humphreys RE
    J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthetic intermediates of HLA class II antigens from B lymphoblastoid cell lines.
    Kelner DN; Cresswell P
    J Immunol; 1986 Oct; 137(8):2632-9. PubMed ID: 3489770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
    Swier K; Miller J
    J Immunol; 1995 Jul; 155(2):630-43. PubMed ID: 7608541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens.
    Shackelford DA; Strominger JL
    J Immunol; 1983 Jan; 130(1):274-82. PubMed ID: 6600184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.
    Machamer CE; Cresswell P
    J Immunol; 1982 Dec; 129(6):2564-9. PubMed ID: 6982931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of invariant chain subsets as a function of their association with MHC class II chains.
    Nguyen QV; Reyes VE; Humphreys RE
    Arch Biochem Biophys; 1995 Feb; 317(1):128-32. PubMed ID: 7872774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant chain retains MHC class II molecules in the endocytic pathway.
    Loss GE; Sant AJ
    J Immunol; 1993 Apr; 150(8 Pt 1):3187-97. PubMed ID: 8468464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L; Kovats S; Eastman S; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation regulates the delivery of MHC class II invariant chain complexes to antigen processing compartments.
    Anderson HA; Roche PA
    J Immunol; 1998 May; 160(10):4850-8. PubMed ID: 9590232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner.
    Lautwein A; Kraus M; Reich M; Burster T; Brandenburg J; Overkleeft HS; Schwarz G; Kammer W; Weber E; Kalbacher H; Nordheim A; Driessen C
    J Leukoc Biol; 2004 May; 75(5):844-55. PubMed ID: 14966190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules.
    Germain RN; Rinker AG
    Nature; 1993 Jun; 363(6431):725-8. PubMed ID: 8515815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.